Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to... More
Briefing
Insights provides context and perspective about key pharmacy trends and issues
Care Management
This white paper presents perspective from Sree Chaguturu, MD, Chief Medical Officer, CVS Caremark about how social... More
White Paper
Care Management
CVS Health addresses diabetes care challenges with its Transform Diabetes Care that offers a customized, clinical, and... More
Briefing
Insights offers context and perspective about key pharmacy and health care topics.
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Care Management
This white paper presents perspective from Sree Chaguturu, MD, Chief Medical Officer, CVS Caremark about how social determinants affect disparities in diabetes including disease burden,... More
White Paper
Care Management
CVS Health addresses diabetes care challenges with its Transform Diabetes Care that offers a customized, clinical, and convenient approach. More
Briefing
Care Management
CVS Health ensures better kidney care using advanced algorithms to drive patient identification and care management. More
Briefing
Cost Management
CVS Health research highlights gaps in diagnosis and treatment of rheumatoid arthritis to help address cost, care, and patient outcomes. More
Briefing
Public Policy
ACA Returns to Court
The California vs. Texas case before the U.S. Supreme Court could help determine the future of the Affordable Care Act (ACA), and could lead to one of several different results. More
Commentary
Specialty
Our proven strategies including step therapy, Specialty Guideline Management, and cross-benefit management can help clients better manage costs for the growing number of IBD treatments. More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2020 - Q1 2021 More
Specialty Report
Public Policy
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity and cost... More
Commentary
Care Management
While the focus is on a possible vaccine for COVID-19, letting rates of immunizations slip for preventable diseases for which vaccines are available can have enormous economically and... More
White Paper